<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-01-01" modified="2022-02-23" version="252">
<accession>P06401</accession>
<accession>A7LQ08</accession>
<accession>A7X8B0</accession>
<accession>B4E3T0</accession>
<accession>Q8TDS3</accession>
<accession>Q9UPF7</accession>
<name>PRGR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Progesterone receptor</fullName>
<shortName>PR</shortName>
</recommendedName>
<alternativeName>
<fullName>Nuclear receptor subfamily 3 group C member 3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PGR</name>
<name type="synonym">NR3C3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="EMBO J." volume="9" first="1603" last="1614">
<title>Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.</title>
<authorList>
<person name="Kastner P."/>
<person name="Krust A."/>
<person name="Turcotte B."/>
<person name="Stropp U."/>
<person name="Tora L."/>
<person name="Gronemeyer H."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="2328727"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1990.tb08280.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>ALTERNATIVE PROMOTER USAGE</scope>
<scope>VARIANT THR-344</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1987" name="Biochem. Biophys. Res. Commun." volume="143" first="740" last="748">
<title>Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA.</title>
<authorList>
<person name="Misrahi M."/>
<person name="Atger M."/>
<person name="D'Auriol L."/>
<person name="Loosfelt H."/>
<person name="Meriel C."/>
<person name="Fridlansky F."/>
<person name="Guiochon-Mantel A."/>
<person name="Galibert F."/>
<person name="Milgrom E."/>
</authorList>
<dbReference type="PubMed" id="3551956"/>
<dbReference type="DOI" id="10.1016/0006-291x(87)91416-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT LEU-660</scope>
</reference>
<reference key="3">
<citation type="submission" date="1997-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Kieback D.G."/>
<person name="Agoulnik I.U."/>
<person name="Tong X.-W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT LEU-660</scope>
</reference>
<reference key="4">
<citation type="submission" date="2002-04" db="EMBL/GenBank/DDBJ databases">
<title>Progesterone Receptor, alternative splicing variant, mRNA.</title>
<authorList>
<person name="Hisatomi H."/>
<person name="Wakita K."/>
<person name="Kohno N."/>
<person name="Nagao K."/>
<person name="Hirata H."/>
<person name="Hikiji K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Mammary tumor</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="Mol. Phylogenet. Evol." volume="47" first="637" last="649">
<title>The human progesterone receptor shows evidence of adaptive evolution associated with its ability to act as a transcription factor.</title>
<authorList>
<person name="Chen C."/>
<person name="Opazo J.C."/>
<person name="Erez O."/>
<person name="Uddin M."/>
<person name="Santolaya-Forgas J."/>
<person name="Goodman M."/>
<person name="Grossman L.I."/>
<person name="Romero R."/>
<person name="Wildman D.E."/>
</authorList>
<dbReference type="PubMed" id="18375150"/>
<dbReference type="DOI" id="10.1016/j.ympev.2007.12.026"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Mol. Cell. Endocrinol." volume="200" first="155" last="163">
<title>Cloning and expression of a novel, truncated, progesterone receptor.</title>
<authorList>
<person name="Saner K.J."/>
<person name="Welter B.H."/>
<person name="Zhang F."/>
<person name="Hansen E."/>
<person name="Dupont B."/>
<person name="Wei Y."/>
<person name="Price T.M."/>
</authorList>
<dbReference type="PubMed" id="12644308"/>
<dbReference type="DOI" id="10.1016/s0303-7207(02)00380-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>ALTERNATIVE PROMOTER USAGE</scope>
<scope>VARIANT LEU-660</scope>
<source>
<tissue>Adipose tissue</tissue>
<tissue>Aorta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2004-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS THR-50; VAL-120; LEU-186; ARG-301; THR-344; SER-444; LEU-529; PRO-536; VAL-651 AND LEU-865</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8475" last="8483">
<title>Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites.</title>
<authorList>
<person name="Knotts T.A."/>
<person name="Orkiszewski R.S."/>
<person name="Cook R.G."/>
<person name="Edwards D.P."/>
<person name="Weigel N.L."/>
</authorList>
<dbReference type="PubMed" id="11110801"/>
<dbReference type="DOI" id="10.1074/jbc.m009805200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 11-22 AND 673-679</scope>
<scope>PHOSPHORYLATION AT SER-20; SER-102; SER-130; SER-162; SER-190; SER-213; SER-345 AND SER-676</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="Mol. Endocrinol." volume="27" first="741" last="753">
<title>A truncated progesterone receptor (PR-M) localizes to the mitochondrion and controls cellular respiration.</title>
<authorList>
<person name="Dai Q."/>
<person name="Shah A.A."/>
<person name="Garde R.V."/>
<person name="Yonish B.A."/>
<person name="Zhang L."/>
<person name="Medvitz N.A."/>
<person name="Miller S.E."/>
<person name="Hansen E.L."/>
<person name="Dunn C.N."/>
<person name="Price T.M."/>
</authorList>
<dbReference type="PubMed" id="23518922"/>
<dbReference type="DOI" id="10.1210/me.2012-1292"/>
</citation>
<scope>PROTEIN SEQUENCE OF 204-217</scope>
<scope>FUNCTION (ISOFORM 4)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 4)</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="10882" last="10887">
<title>A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms.</title>
<authorList>
<person name="Meyer M.E."/>
<person name="Quirin-Stricker C."/>
<person name="Lerouge T."/>
<person name="Bocquel M.T."/>
<person name="Gronemeyer H."/>
</authorList>
<dbReference type="PubMed" id="1587864"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="17617" last="17623">
<title>Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).</title>
<authorList>
<person name="Ing N.H."/>
<person name="Beekman J.M."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="1517211"/>
</citation>
<scope>INTERACTION WITH GTF2B</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="1244" last="1255">
<title>Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.</title>
<authorList>
<person name="Vegeto E."/>
<person name="Shahbaz M.M."/>
<person name="Wen D.X."/>
<person name="Goldman M.E."/>
<person name="O'Malley B.W."/>
<person name="McDonnell D.P."/>
</authorList>
<dbReference type="PubMed" id="8264658"/>
<dbReference type="DOI" id="10.1210/mend.7.10.8264658"/>
</citation>
<scope>FUNCTION (ISOFORM A)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1994" name="J. Steroid Biochem. Mol. Biol." volume="48" first="425" last="432">
<title>The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity.</title>
<authorList>
<person name="McDonnell D.P."/>
<person name="Shahbaz M.M."/>
<person name="Vegeto E."/>
<person name="Goldman M.E."/>
</authorList>
<dbReference type="PubMed" id="8180103"/>
<dbReference type="DOI" id="10.1016/0960-0760(94)90190-2"/>
</citation>
<scope>FUNCTION (ISOFORM A)</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1994" name="Mol. Cell. Biol." volume="14" first="8356" last="8364">
<title>The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.</title>
<authorList>
<person name="Wen D.X."/>
<person name="Xu Y.F."/>
<person name="Mais D.E."/>
<person name="Goldman M.E."/>
<person name="McDonnell D.P."/>
</authorList>
<dbReference type="PubMed" id="7969170"/>
<dbReference type="DOI" id="10.1128/mcb.14.12.8356-8364.1994"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1995" name="Mol. Endocrinol." volume="9" first="1029" last="1040">
<title>Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Beck C.A."/>
<person name="Poletti A."/>
<person name="Edwards D.P."/>
<person name="Weigel N.L."/>
</authorList>
<dbReference type="PubMed" id="7476977"/>
<dbReference type="DOI" id="10.1210/mend.9.8.7476977"/>
</citation>
<scope>PHOSPHORYLATION AT SER-81 AND SER-162</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="19546" last="19555">
<title>Stoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system.</title>
<authorList>
<person name="Beck C.A."/>
<person name="Zhang Y."/>
<person name="Altmann M."/>
<person name="Weigel N.L."/>
<person name="Edwards D.P."/>
</authorList>
<dbReference type="PubMed" id="8702648"/>
<dbReference type="DOI" id="10.1074/jbc.271.32.19546"/>
</citation>
<scope>PHOSPHORYLATION AT SER-81; SER-102; SER-162; SER-294 AND SER-345</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="32889" last="32900">
<title>Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor.</title>
<authorList>
<person name="Giangrande P.H."/>
<person name="Pollio G."/>
<person name="McDonnell D.P."/>
</authorList>
<dbReference type="PubMed" id="9407067"/>
<dbReference type="DOI" id="10.1074/jbc.272.52.32889"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1997" name="Mol. Endocrinol." volume="11" first="823" last="832">
<title>Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Beck C.A."/>
<person name="Poletti A."/>
<person name="Clement J.P. IV"/>
<person name="Prendergast P."/>
<person name="Yip T.-T."/>
<person name="Hutchens T.W."/>
<person name="Edwards D.P."/>
<person name="Weigel N.L."/>
</authorList>
<dbReference type="PubMed" id="9171245"/>
<dbReference type="DOI" id="10.1210/mend.11.6.0006"/>
</citation>
<scope>PHOSPHORYLATION AT SER-162; SER-190 AND SER-400</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2000" name="Hum. Reprod." volume="15" first="48" last="56">
<title>Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma.</title>
<authorList>
<person name="Mote P.A."/>
<person name="Balleine R.L."/>
<person name="McGowan E.M."/>
<person name="Clarke C.L."/>
</authorList>
<dbReference type="PubMed" id="11041221"/>
<dbReference type="DOI" id="10.1093/humrep/15.suppl_3.48"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3102" last="3115">
<title>The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.</title>
<authorList>
<person name="Giangrande P.H."/>
<person name="Kimbrel E.A."/>
<person name="Edwards D.P."/>
<person name="McDonnell D.P."/>
</authorList>
<dbReference type="PubMed" id="10757795"/>
<dbReference type="DOI" id="10.1128/mcb.20.9.3102-3115.2000"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCOR2; NCOA2 AND NCOA1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2000" name="Mol. Endocrinol." volume="14" first="52" last="65">
<title>Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody.</title>
<authorList>
<person name="Clemm D.L."/>
<person name="Sherman L."/>
<person name="Boonyaratanakornkit V."/>
<person name="Schrader W.T."/>
<person name="Weigel N.L."/>
<person name="Edwards D.P."/>
</authorList>
<dbReference type="PubMed" id="10628747"/>
<dbReference type="DOI" id="10.1210/mend.14.1.0413"/>
</citation>
<scope>PHOSPHORYLATION AT SER-190 AND SER-294</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="1032" last="1037">
<title>Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.</title>
<authorList>
<person name="Lange C.A."/>
<person name="Shen T."/>
<person name="Horwitz K.B."/>
</authorList>
<dbReference type="PubMed" id="10655479"/>
<dbReference type="DOI" id="10.1073/pnas.97.3.1032"/>
</citation>
<scope>PHOSPHORYLATION AT SER-294</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-294; SER-344 AND SER-345</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="39843" last="39851">
<title>Mapping the unique activation function 3 in the progesterone B-receptor upstream segment. Two LXXLL motifs and a tryptophan residue are required for activity.</title>
<authorList>
<person name="Tung L."/>
<person name="Shen T."/>
<person name="Abel M.G."/>
<person name="Powell R.L."/>
<person name="Takimoto G.S."/>
<person name="Sartorius C.A."/>
<person name="Horwitz K.B."/>
</authorList>
<dbReference type="PubMed" id="11546784"/>
<dbReference type="DOI" id="10.1074/jbc.m106843200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LEU-55; LEU-58; LEU-59; LEU-115; LEU-118; LEU-119 AND TRP-140</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="28624" last="28630">
<title>Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.</title>
<authorList>
<person name="Qi C."/>
<person name="Chang J."/>
<person name="Zhu Y."/>
<person name="Yeldandi A.V."/>
<person name="Rao S.M."/>
<person name="Zhu Y.-J."/>
</authorList>
<dbReference type="PubMed" id="12039952"/>
<dbReference type="DOI" id="10.1074/jbc.m201053200"/>
</citation>
<scope>INTERACTION WITH PRMT2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="6210" last="6220">
<title>BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation.</title>
<authorList>
<person name="Hsiao P.W."/>
<person name="Fryer C.J."/>
<person name="Trotter K.W."/>
<person name="Wang W."/>
<person name="Archer T.K."/>
</authorList>
<dbReference type="PubMed" id="12917342"/>
<dbReference type="DOI" id="10.1128/mcb.23.17.6210-6220.2003"/>
</citation>
<scope>INTERACTION WITH SMARD1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="10542" last="10557">
<title>Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.</title>
<authorList>
<person name="Pierson-Mullany L.K."/>
<person name="Lange C.A."/>
</authorList>
<dbReference type="PubMed" id="15572662"/>
<dbReference type="DOI" id="10.1128/mcb.24.24.10542-10557.2004"/>
</citation>
<scope>PHOSPHORYLATION AT SER-400</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-400</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="2885" last="2898">
<title>Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.</title>
<authorList>
<person name="Narayanan R."/>
<person name="Edwards D.P."/>
<person name="Weigel N.L."/>
</authorList>
<dbReference type="PubMed" id="15798179"/>
<dbReference type="DOI" id="10.1128/mcb.25.8.2885-2898.2005"/>
</citation>
<scope>PHOSPHORYLATION AT SER-162; SER-190 AND SER-294</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="1722" last="1730">
<title>GCUNC-45 is a novel regulator for the progesterone receptor/hsp90 chaperoning pathway.</title>
<authorList>
<person name="Chadli A."/>
<person name="Graham J.D."/>
<person name="Abel M.G."/>
<person name="Jackson T.A."/>
<person name="Gordon D.F."/>
<person name="Wood W.M."/>
<person name="Felts S.J."/>
<person name="Horwitz K.B."/>
<person name="Toft D."/>
</authorList>
<dbReference type="PubMed" id="16478993"/>
<dbReference type="DOI" id="10.1128/mcb.26.5.1722-1730.2006"/>
</citation>
<scope>INTERACTION WITH UNC45A</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Nucleic Acids Res." volume="34" first="5552" last="5566">
<title>PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus.</title>
<authorList>
<person name="Man J.-H."/>
<person name="Li H.-Y."/>
<person name="Zhang P.-J."/>
<person name="Zhou T."/>
<person name="He K."/>
<person name="Pan X."/>
<person name="Liang B."/>
<person name="Li A.-L."/>
<person name="Zhao J."/>
<person name="Gong W.-L."/>
<person name="Jin B.-F."/>
<person name="Xia Q."/>
<person name="Yu M."/>
<person name="Shen B.-F."/>
<person name="Zhang X.-M."/>
</authorList>
<dbReference type="PubMed" id="17020914"/>
<dbReference type="DOI" id="10.1093/nar/gkl691"/>
</citation>
<scope>SUMOYLATION AT LYS-7; LYS-388 AND LYS-531</scope>
<scope>INTERACTION WITH PIAS3</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-7; LYS-388 AND LYS-531</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="1831" last="1842">
<title>CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.</title>
<authorList>
<person name="Zhang P.-J."/>
<person name="Zhao J."/>
<person name="Li H.-Y."/>
<person name="Man J.-H."/>
<person name="He K."/>
<person name="Zhou T."/>
<person name="Pan X."/>
<person name="Li A.-L."/>
<person name="Gong W.-L."/>
<person name="Jin B.-F."/>
<person name="Xia Q."/>
<person name="Yu M."/>
<person name="Shen B.-F."/>
<person name="Zhang X.-M."/>
</authorList>
<dbReference type="PubMed" id="17347654"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601602"/>
</citation>
<scope>INTERACTION WITH CUEDC2</scope>
<scope>SUMOYLATION AT LYS-388</scope>
<scope>UBIQUITINATION AT LYS-388</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-388</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Mol. Endocrinol." volume="21" first="2890" last="2906">
<title>Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.</title>
<authorList>
<person name="Daniel A.R."/>
<person name="Faivre E.J."/>
<person name="Lange C.A."/>
</authorList>
<dbReference type="PubMed" id="17717077"/>
<dbReference type="DOI" id="10.1210/me.2007-0248"/>
</citation>
<scope>PHOSPHORYLATION AT SER-294</scope>
<scope>SUMOYLATION AT LYS-388</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-294 AND LYS-388</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Steroids" volume="72" first="188" last="201">
<title>Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.</title>
<authorList>
<person name="Daniel A.R."/>
<person name="Qiu M."/>
<person name="Faivre E.J."/>
<person name="Ostrander J.H."/>
<person name="Skildum A."/>
<person name="Lange C.A."/>
</authorList>
<dbReference type="PubMed" id="17173941"/>
<dbReference type="DOI" id="10.1016/j.steroids.2006.11.009"/>
</citation>
<scope>PHOSPHORYLATION AT SER-294</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-294</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Mol. Endocrinol." volume="22" first="823" last="837">
<title>Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.</title>
<authorList>
<person name="Faivre E.J."/>
<person name="Daniel A.R."/>
<person name="Hillard C.J."/>
<person name="Lange C.A."/>
</authorList>
<dbReference type="PubMed" id="18202149"/>
<dbReference type="DOI" id="10.1210/me.2007-0437"/>
</citation>
<scope>PHOSPHORYLATION AT SER-294; SER-345 AND SER-400</scope>
<scope>INTERACTION WITH SP1</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-344; SER-345 AND SER-400</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="188" last="199">
<title>DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors.</title>
<authorList>
<person name="Pedram A."/>
<person name="Razandi M."/>
<person name="Deschenes R.J."/>
<person name="Levin E.R."/>
</authorList>
<dbReference type="PubMed" id="22031296"/>
<dbReference type="DOI" id="10.1091/mbc.e11-07-0638"/>
</citation>
<scope>PALMITOYLATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="1998" name="Nature" volume="393" first="392" last="396">
<title>Atomic structure of progesterone complexed with its receptor.</title>
<authorList>
<person name="Williams S.P."/>
<person name="Sigler P.B."/>
</authorList>
<dbReference type="PubMed" id="9620806"/>
<dbReference type="DOI" id="10.1038/30775"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 682-933</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28468" last="28475">
<title>Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Olland A.M."/>
<person name="Zhu Y."/>
<person name="Cohen J."/>
<person name="Berrodin T."/>
<person name="Chippari S."/>
<person name="Appavu C."/>
<person name="Li S."/>
<person name="Wilhem J."/>
<person name="Chopra R."/>
<person name="Fensome A."/>
<person name="Zhang P."/>
<person name="Wrobel J."/>
<person name="Unwalla R.J."/>
<person name="Lyttle C.R."/>
<person name="Winneker R.C."/>
</authorList>
<dbReference type="PubMed" id="15937332"/>
<dbReference type="DOI" id="10.1074/jbc.m504144200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 676-933</scope>
</reference>
<comment type="function">
<text evidence="8 18 35 41">The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as transcriptional activator or repressor.</text>
</comment>
<comment type="function">
<molecule>Isoform A</molecule>
<text evidence="30 31 32 41 42">Ligand-dependent transdominant repressor of steroid hormone receptor transcriptional activity including repression of its isoform B, MR and ER. Transrepressional activity may involve recruitment of corepressor NCOR2.</text>
</comment>
<comment type="function">
<molecule>Isoform B</molecule>
<text evidence="30">Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation.</text>
</comment>
<comment type="function">
<molecule>Isoform 4</molecule>
<text>Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.</text>
</comment>
<comment type="subunit">
<text evidence="1 8 12 14 15 19 20 22 24">Interacts with SMARD1 and UNC45A. Interacts with CUEDC2; the interaction promotes ubiquitination, decreases sumoylation, and represses transcriptional activity. Interacts with PIAS3; the interaction promotes sumoylation of PR in a hormone-dependent manner, inhibits DNA-binding, and alters nuclear export. Interacts with SP1; the interaction requires ligand-induced phosphorylation on Ser-345 by ERK1/2 MAPK. Interacts with PRMT2. Isoform A interacts with NCOR2. Isoform B (but not isoform A) interacts with NCOA2 and NCOA1. Isoform B (but not isoform A) interacts with KLF9. Interacts with GTF2B (PubMed:1517211).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78539">
<id>P06401</id>
</interactant>
<interactant intactId="EBI-1248228">
<id>Q9H467</id>
<label>CUEDC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78539">
<id>P06401</id>
</interactant>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78539">
<id>P06401</id>
</interactant>
<interactant intactId="EBI-78539">
<id>P06401</id>
<label>PGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78539">
<id>P06401</id>
</interactant>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12590474">
<id>P06401-1</id>
</interactant>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Nucleoplasmic shuttling is both hormone- and cell cycle-dependent. On hormone stimulation, retained in the cytoplasm in the G(1) and G(2)/M phases.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform A</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Mainly nuclear.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location evidence="27">Mitochondrion outer membrane</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<event type="alternative splicing"/>
<isoform>
<id>P06401-1</id>
<name>B</name>
<name>PRB</name>
<name>PR-B</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P06401-2</id>
<name>A</name>
<name>PRA</name>
<name>PR-A</name>
<sequence type="described" ref="VSP_003706"/>
</isoform>
<isoform>
<id>P06401-3</id>
<name>3</name>
<sequence type="described" ref="VSP_046942"/>
</isoform>
<isoform>
<id>P06401-4</id>
<name>4</name>
<name>PR-M</name>
<sequence type="described" ref="VSP_047454 VSP_047455"/>
</isoform>
<isoform>
<id>P06401-5</id>
<name>5</name>
<name>delta4</name>
<sequence type="described" ref="VSP_053543"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="9">In reproductive tissues the expression of isoform A and isoform B varies as a consequence of developmental and hormonal status. Isoform A and isoform B are expressed in comparable levels in uterine glandular epithelium during the proliferative phase of the menstrual cycle. Expression of isoform B but not of isoform A persists in the glands during mid-secretory phase. In the stroma, isoform A is the predominant form throughout the cycle. Heterogeneous isoform expression between the glands of the endometrium basalis and functionalis is implying region-specific responses to hormonal stimuli.</text>
</comment>
<comment type="domain">
<text>Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.</text>
</comment>
<comment type="PTM">
<text evidence="6 7 10 16 17 20 21 22 23 24 29 33 34">Phosphorylated on multiple serine sites. Several of these sites are hormone-dependent. Phosphorylation on Ser-294 occurs preferentially on isoform B, is highly hormone-dependent and modulates ubiquitination and sumoylation on Lys-388. Phosphorylation on Ser-102 and Ser-345 also requires induction by hormone. Basal phosphorylation on Ser-81, Ser-162, Ser-190 and Ser-400 is increased in response to progesterone and can be phosphorylated in vitro by the CDK2-A1 complex. Increased levels of phosphorylation on Ser-400 also in the presence of EGF, heregulin, IGF, PMA and FBS. Phosphorylation at this site by CDK2 is ligand-independent, and increases nuclear translocation and transcriptional activity. Phosphorylation at Ser-162 and Ser-294, but not at Ser-190, is impaired during the G(2)/M phase of the cell cycle. Phosphorylation on Ser-345 by ERK1/2 MAPK is required for interaction with SP1.</text>
</comment>
<comment type="PTM">
<text evidence="6 7 17 20 21 22 23 24 33">Sumoylation is hormone-dependent and represses transcriptional activity. Sumoylation on all three sites is enhanced by PIAS3. Desumoylated by SENP1. Sumoylation on Lys-388, the main site of sumoylation, is repressed by ubiquitination on the same site, and modulated by phosphorylation at Ser-294.</text>
</comment>
<comment type="PTM">
<text evidence="6 7 17 21 23 24 33">Ubiquitination is hormone-dependent and represses sumoylation on the same site. Promoted by MAPK-mediated phosphorylation on Ser-294.</text>
</comment>
<comment type="PTM">
<text evidence="25">Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform B</molecule>
<text>Produced by alternative promoter usage.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform A</molecule>
<text evidence="41">Produced by alternative promoter usage.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="41">Produced by alternative splicing of isoform B.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 4</molecule>
<text evidence="41">Produced by alternative promoter usage.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 5</molecule>
<text evidence="41">Produced by alternative splicing of isoform B.</text>
</comment>
<comment type="similarity">
<text evidence="41">Belongs to the nuclear hormone receptor family. NR3 subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/pgr/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Progesterone_receptor"/>
<text>Progesterone receptor entry</text>
</comment>
<dbReference type="EMBL" id="X51730">
<property type="protein sequence ID" value="CAA36018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M15716">
<property type="protein sequence ID" value="AAA60081.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF016381">
<property type="protein sequence ID" value="AAD01587.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB084248">
<property type="protein sequence ID" value="BAB91074.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ234979">
<property type="protein sequence ID" value="ABB72139.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY212933">
<property type="protein sequence ID" value="AAO61671.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304853">
<property type="protein sequence ID" value="BAG65592.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY525610">
<property type="protein sequence ID" value="AAS00096.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001533">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471065">
<property type="protein sequence ID" value="EAW66999.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471065">
<property type="protein sequence ID" value="EAW67000.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59229.1">
<molecule id="P06401-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8310.1">
<molecule id="P06401-1"/>
</dbReference>
<dbReference type="PIR" id="S09971">
<property type="entry name" value="QRHUP"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000917.3">
<molecule id="P06401-1"/>
<property type="nucleotide sequence ID" value="NM_000926.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001189403.1">
<molecule id="P06401-2"/>
<property type="nucleotide sequence ID" value="NM_001202474.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001258090.1">
<property type="nucleotide sequence ID" value="NM_001271161.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001258091.1">
<molecule id="P06401-3"/>
<property type="nucleotide sequence ID" value="NM_001271162.1"/>
</dbReference>
<dbReference type="PDB" id="1A28">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="1E3K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80 A"/>
<property type="chains" value="A/B=676-933"/>
</dbReference>
<dbReference type="PDB" id="1SQN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45 A"/>
<property type="chains" value="A/B=673-933"/>
</dbReference>
<dbReference type="PDB" id="1SR7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.46 A"/>
<property type="chains" value="A/B=676-933"/>
</dbReference>
<dbReference type="PDB" id="1ZUC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00 A"/>
<property type="chains" value="A/B=676-933"/>
</dbReference>
<dbReference type="PDB" id="2C7A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50 A"/>
<property type="chains" value="A/B=563-640"/>
</dbReference>
<dbReference type="PDB" id="2OVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00 A"/>
<property type="chains" value="A=678-933"/>
</dbReference>
<dbReference type="PDB" id="2OVM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60 A"/>
<property type="chains" value="A=678-933"/>
</dbReference>
<dbReference type="PDB" id="2W8Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="3D90">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26 A"/>
<property type="chains" value="A/B=676-933"/>
</dbReference>
<dbReference type="PDB" id="3G8O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90 A"/>
<property type="chains" value="A/B=673-933"/>
</dbReference>
<dbReference type="PDB" id="3HQ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="3KBA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00 A"/>
<property type="chains" value="A/B=681-933"/>
</dbReference>
<dbReference type="PDB" id="3ZR7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="3ZRA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="3ZRB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="4A2J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="4APU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90 A"/>
<property type="chains" value="A/B=678-933"/>
</dbReference>
<dbReference type="PDB" id="4OAR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41 A"/>
<property type="chains" value="A=678-933"/>
</dbReference>
<dbReference type="PDB" id="5CC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40 A"/>
<property type="chains" value="A/B=561-641"/>
</dbReference>
<dbReference type="PDBsum" id="1A28"/>
<dbReference type="PDBsum" id="1E3K"/>
<dbReference type="PDBsum" id="1SQN"/>
<dbReference type="PDBsum" id="1SR7"/>
<dbReference type="PDBsum" id="1ZUC"/>
<dbReference type="PDBsum" id="2C7A"/>
<dbReference type="PDBsum" id="2OVH"/>
<dbReference type="PDBsum" id="2OVM"/>
<dbReference type="PDBsum" id="2W8Y"/>
<dbReference type="PDBsum" id="3D90"/>
<dbReference type="PDBsum" id="3G8O"/>
<dbReference type="PDBsum" id="3HQ5"/>
<dbReference type="PDBsum" id="3KBA"/>
<dbReference type="PDBsum" id="3ZR7"/>
<dbReference type="PDBsum" id="3ZRA"/>
<dbReference type="PDBsum" id="3ZRB"/>
<dbReference type="PDBsum" id="4A2J"/>
<dbReference type="PDBsum" id="4APU"/>
<dbReference type="PDBsum" id="4OAR"/>
<dbReference type="PDBsum" id="5CC0"/>
<dbReference type="SMR" id="P06401"/>
<dbReference type="BioGRID" id="111260">
<property type="interactions" value="70"/>
</dbReference>
<dbReference type="DIP" id="DIP-5967N"/>
<dbReference type="ELM" id="P06401"/>
<dbReference type="IntAct" id="P06401">
<property type="interactions" value="89"/>
</dbReference>
<dbReference type="MINT" id="P06401"/>
<dbReference type="STRING" id="9606.ENSP00000325120"/>
<dbReference type="BindingDB" id="P06401"/>
<dbReference type="ChEMBL" id="CHEMBL208"/>
<dbReference type="DrugBank" id="DB01431">
<property type="generic name" value="Allylestrenol"/>
</dbReference>
<dbReference type="DrugBank" id="DB06680">
<property type="generic name" value="Asoprisnil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01406">
<property type="generic name" value="Danazol"/>
</dbReference>
<dbReference type="DrugBank" id="DB12941">
<property type="generic name" value="Darolutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB13857">
<property type="generic name" value="Demegestone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00304">
<property type="generic name" value="Desogestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB09123">
<property type="generic name" value="Dienogest"/>
</dbReference>
<dbReference type="DrugBank" id="DB01395">
<property type="generic name" value="Drospirenone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00378">
<property type="generic name" value="Dydrogesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB11219">
<property type="generic name" value="Enzacamene"/>
</dbReference>
<dbReference type="DrugBank" id="DB00823">
<property type="generic name" value="Ethynodiol diacetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00294">
<property type="generic name" value="Etonogestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB13867">
<property type="generic name" value="Fluticasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08906">
<property type="generic name" value="Fluticasone furoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00588">
<property type="generic name" value="Fluticasone propionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06730">
<property type="generic name" value="Gestodene"/>
</dbReference>
<dbReference type="DrugBank" id="DB11619">
<property type="generic name" value="Gestrinone"/>
</dbReference>
<dbReference type="DrugBank" id="DB11064">
<property type="generic name" value="Homosalate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06789">
<property type="generic name" value="Hydroxyprogesterone caproate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00367">
<property type="generic name" value="Levonorgestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB00431">
<property type="generic name" value="Lindane"/>
</dbReference>
<dbReference type="DrugBank" id="DB09124">
<property type="generic name" value="Medrogestone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00603">
<property type="generic name" value="Medroxyprogesterone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00351">
<property type="generic name" value="Megestrol acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB02998">
<property type="generic name" value="Metribolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00834">
<property type="generic name" value="Mifepristone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00648">
<property type="generic name" value="Mitotane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00764">
<property type="generic name" value="Mometasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB14512">
<property type="generic name" value="Mometasone furoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06713">
<property type="generic name" value="Norelgestromin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00717">
<property type="generic name" value="Norethisterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00957">
<property type="generic name" value="Norgestimate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09389">
<property type="generic name" value="Norgestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB01428">
<property type="generic name" value="Oxybenzone"/>
</dbReference>
<dbReference type="DrugBank" id="DB02746">
<property type="generic name" value="Phthalic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00396">
<property type="generic name" value="Progesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB14583">
<property type="generic name" value="Segesterone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00421">
<property type="generic name" value="Spironolactone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04787">
<property type="generic name" value="Tanaproget"/>
</dbReference>
<dbReference type="DrugBank" id="DB05253">
<property type="generic name" value="Telapristone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB08867">
<property type="generic name" value="Ulipristal"/>
</dbReference>
<dbReference type="DrugCentral" id="P06401"/>
<dbReference type="GuidetoPHARMACOLOGY" id="627"/>
<dbReference type="SwissLipids" id="SLP:000001574"/>
<dbReference type="TCDB" id="9.B.208.1.5">
<property type="family name" value="the vitamin d3 receptor (vdr) family"/>
</dbReference>
<dbReference type="GlyGen" id="P06401">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="P06401"/>
<dbReference type="PhosphoSitePlus" id="P06401"/>
<dbReference type="SwissPalm" id="P06401"/>
<dbReference type="BioMuta" id="PGR"/>
<dbReference type="DMDM" id="90110048"/>
<dbReference type="jPOST" id="P06401"/>
<dbReference type="MassIVE" id="P06401"/>
<dbReference type="MaxQB" id="P06401"/>
<dbReference type="PaxDb" id="P06401"/>
<dbReference type="PeptideAtlas" id="P06401"/>
<dbReference type="PRIDE" id="P06401"/>
<dbReference type="ProteomicsDB" id="51901">
<molecule id="P06401-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51902">
<molecule id="P06401-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="5919"/>
<dbReference type="ProteomicsDB" id="74334"/>
<dbReference type="Antibodypedia" id="1685">
<property type="antibodies" value="2968 antibodies from 54 providers"/>
</dbReference>
<dbReference type="CPTC" id="P06401">
<property type="antibodies" value="2 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5241"/>
<dbReference type="Ensembl" id="ENST00000263463">
<molecule id="P06401-5"/>
<property type="protein sequence ID" value="ENSP00000263463"/>
<property type="gene ID" value="ENSG00000082175"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000325455">
<property type="protein sequence ID" value="ENSP00000325120"/>
<property type="gene ID" value="ENSG00000082175"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000534013">
<molecule id="P06401-3"/>
<property type="protein sequence ID" value="ENSP00000436561"/>
<property type="gene ID" value="ENSG00000082175"/>
</dbReference>
<dbReference type="GeneID" id="5241"/>
<dbReference type="KEGG" id="hsa:5241"/>
<dbReference type="MANE-Select" id="ENST00000325455.10">
<property type="protein sequence ID" value="ENSP00000325120.5"/>
<property type="RefSeq nucleotide sequence ID" value="NM_000926.4"/>
<property type="RefSeq protein sequence ID" value="NP_000917.3"/>
</dbReference>
<dbReference type="UCSC" id="uc001pgh.3">
<molecule id="P06401-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5241"/>
<dbReference type="DisGeNET" id="5241"/>
<dbReference type="GeneCards" id="PGR"/>
<dbReference type="HGNC" id="HGNC:8910">
<property type="gene designation" value="PGR"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000082175">
<property type="expression patterns" value="Group enriched (cervix, endometrium, fallopian tube, smooth muscle)"/>
</dbReference>
<dbReference type="MalaCards" id="PGR"/>
<dbReference type="MIM" id="607311">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P06401"/>
<dbReference type="OpenTargets" id="ENSG00000082175"/>
<dbReference type="PharmGKB" id="PA266"/>
<dbReference type="VEuPathDB" id="HostDB:ENSG00000082175"/>
<dbReference type="eggNOG" id="KOG3575">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159713"/>
<dbReference type="HOGENOM" id="CLU_014081_0_0_1"/>
<dbReference type="InParanoid" id="P06401"/>
<dbReference type="OMA" id="YKAEGAQ"/>
<dbReference type="OrthoDB" id="615449at2759"/>
<dbReference type="PhylomeDB" id="P06401"/>
<dbReference type="TreeFam" id="TF106510"/>
<dbReference type="PathwayCommons" id="P06401"/>
<dbReference type="Reactome" id="R-HSA-1251985">
<property type="pathway name" value="Nuclear signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371497">
<property type="pathway name" value="HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-383280">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4090294">
<property type="pathway name" value="SUMOylation of intracellular receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="SignaLink" id="P06401"/>
<dbReference type="SIGNOR" id="P06401"/>
<dbReference type="BioGRID-ORCS" id="5241">
<property type="hits" value="3 hits in 1065 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PGR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P06401"/>
<dbReference type="GeneWiki" id="Progesterone_receptor"/>
<dbReference type="GenomeRNAi" id="5241"/>
<dbReference type="Pharos" id="P06401">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P06401"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="P06401">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000082175">
<property type="expression patterns" value="Expressed in endometrium and 173 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P06401">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P06401">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005741">
<property type="term" value="C:mitochondrial outer membrane"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051117">
<property type="term" value="F:ATPase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005496">
<property type="term" value="F:steroid binding"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003707">
<property type="term" value="F:steroid hormone receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001223">
<property type="term" value="F:transcription coactivator binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002070">
<property type="term" value="P:epithelial cell maturation"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030518">
<property type="term" value="P:intracellular steroid hormone receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048286">
<property type="term" value="P:lung alveolus development"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001542">
<property type="term" value="P:ovulation from ovarian follicle"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038001">
<property type="term" value="P:paracrine signaling"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0050847">
<property type="term" value="P:progesterone receptor signaling pathway"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050678">
<property type="term" value="P:regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060748">
<property type="term" value="P:tertiary branching involved in mammary gland duct morphogenesis"/>
<property type="evidence" value="ECO:0007669"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="DisProt" id="DP01542"/>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001723">
<property type="entry name" value="Nuclear_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000128">
<property type="entry name" value="Progest_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02161">
<property type="entry name" value="Prog_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00544">
<property type="entry name" value="PROGESTRONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00398">
<property type="entry name" value="STRDHORMONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-1000">Mitochondrion outer membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0754">Steroid-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Progesterone receptor" id="PRO_0000053693">
<location>
<begin position="1"/>
<end position="933"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="4">
<location>
<begin position="679"/>
<end position="913"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="3">
<location>
<begin position="567"/>
<end position="639"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="3">
<location>
<begin position="567"/>
<end position="587"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="3">
<location>
<begin position="603"/>
<end position="627"/>
</location>
</feature>
<feature type="region of interest" description="Modulating, Pro-Rich">
<location>
<begin position="1"/>
<end position="566"/>
</location>
</feature>
<feature type="region of interest" description="AF3; mediates transcriptional activation (in isoform B)" evidence="11">
<location>
<begin position="1"/>
<end position="164"/>
</location>
</feature>
<feature type="region of interest" description="Disordered" evidence="5">
<location>
<begin position="1"/>
<end position="157"/>
</location>
</feature>
<feature type="region of interest" description="Mediates transcriptional transrepression (in isoform A)" evidence="35">
<location>
<begin position="165"/>
<end position="305"/>
</location>
</feature>
<feature type="region of interest" description="Disordered" evidence="5">
<location>
<begin position="195"/>
<end position="241"/>
</location>
</feature>
<feature type="region of interest" description="Disordered" evidence="5">
<location>
<begin position="331"/>
<end position="351"/>
</location>
</feature>
<feature type="region of interest" description="Disordered" evidence="5">
<location>
<begin position="415"/>
<end position="452"/>
</location>
</feature>
<feature type="region of interest" description="AF1; mediates transcriptional activation" evidence="18">
<location>
<begin position="456"/>
<end position="546"/>
</location>
</feature>
<feature type="region of interest" description="AF2; mediates transcriptional activation" evidence="18">
<location>
<begin position="687"/>
<end position="933"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXL motif 1" evidence="43">
<location>
<begin position="55"/>
<end position="59"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXL motif 2" evidence="43">
<location>
<begin position="115"/>
<end position="119"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="2">
<location>
<begin position="183"/>
<end position="187"/>
</location>
</feature>
<feature type="compositionally biased region" description="Polar residues" evidence="5">
<location>
<begin position="68"/>
<end position="84"/>
</location>
</feature>
<feature type="compositionally biased region" description="Polar residues" evidence="5">
<location>
<begin position="120"/>
<end position="135"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro residues" evidence="5">
<location>
<begin position="415"/>
<end position="431"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29 33">
<location>
<position position="81"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 33">
<location>
<position position="102"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="130"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 17 29 33 34 44">
<location>
<position position="162"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 10 17 34">
<location>
<position position="190"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="213"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1" evidence="6 7 17 21 23 24 33">
<location>
<position position="294"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK" evidence="10 24 33">
<location>
<position position="345"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2" evidence="16 24 34">
<location>
<position position="400"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="676"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="20">
<location>
<position position="7"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="388"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="22">
<location>
<position position="388"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="20">
<location>
<position position="531"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_046942" evidence="39">
<location>
<begin position="1"/>
<end position="594"/>
</location>
</feature>
<feature type="splice variant" description="In isoform A." id="VSP_003706" evidence="41">
<location>
<begin position="1"/>
<end position="164"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_047454" evidence="38">
<original>MTELKAKGPRAPHVAG</original>
<variation>MEFIYIYMNFFFFFSV</variation>
<location>
<begin position="1"/>
<end position="16"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_047455" evidence="38">
<location>
<begin position="17"/>
<end position="635"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_053543" evidence="40">
<location>
<begin position="636"/>
<end position="737"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571143." id="VAR_019221" evidence="37">
<original>A</original>
<variation>T</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571144." id="VAR_019222" evidence="37">
<original>A</original>
<variation>V</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571145." id="VAR_019223" evidence="37">
<original>P</original>
<variation>L</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571146." id="VAR_019224" evidence="37">
<original>M</original>
<variation>R</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3740753." id="VAR_016117" evidence="26 37">
<original>S</original>
<variation>T</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571147." id="VAR_025555">
<original>C</original>
<variation>S</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571150." id="VAR_019225" evidence="37">
<original>A</original>
<variation>S</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571151." id="VAR_019226" evidence="37">
<original>V</original>
<variation>L</variation>
<location>
<position position="529"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571152." id="VAR_019227" evidence="37">
<original>Q</original>
<variation>P</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2020874." id="VAR_014627">
<original>R</original>
<variation>I</variation>
<location>
<position position="625"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571222." id="VAR_019228" evidence="37">
<original>L</original>
<variation>V</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1042838." id="VAR_016118" evidence="13 28 36">
<original>V</original>
<variation>L</variation>
<location>
<position position="660"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2020880." id="VAR_014628" evidence="37">
<original>S</original>
<variation>L</variation>
<location>
<position position="865"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some loss of sumoylation; when associated with R-531. Complete loss of sumoylation; when associated with R-388 and R-531." evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcriptional activation; when associated with A-58 and A-59." evidence="11">
<original>L</original>
<variation>A</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcriptional activation; when associated with A-55 and A-59." evidence="11">
<original>L</original>
<variation>A</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcriptional activation; when associated with A-55 and A-58." evidence="11">
<original>L</original>
<variation>A</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcriptional activation; when associated with A-118 and A-119." evidence="11">
<original>L</original>
<variation>A</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcriptional activation; when associated with A-115 and A-119." evidence="11">
<original>L</original>
<variation>A</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcriptional activation; when associated with A-115 and A-118." evidence="11">
<original>L</original>
<variation>A</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcriptional activation." evidence="11">
<original>W</original>
<variation>A</variation>
<variation>F</variation>
<variation>R</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with CUEDC2. Impaired progesterone-induced transcriptional activity. No CUEDC2- nor progestin-mediated protein degradation. No change in sumoylation; when associated with A-344 and A-345." evidence="7 21 23">
<original>S</original>
<variation>A</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases protein stability and increases progesterone-induced transcriptional activity." evidence="7 21 23">
<original>S</original>
<variation>D</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="mutagenesis site" description="No interaction with SP1. No change in progestin-induced protein degradation; when associated with A-345. No change in sumoylation; when associated with A-294 and A-345." evidence="7 24">
<original>S</original>
<variation>A</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in progestin-induced protein degradation; when associated with A-344. No change in sumoylation; when associated with A-294 and A-344." evidence="7 24">
<original>S</original>
<variation>A</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Great loss of sumoylation; when associated with R-7. Completely abolishes sumoylation; when associated with R-7 and R-531. Loss of CUEDC2-mediated protein degradation. Increased ligand-dependent transcriptional activity." evidence="20 22 23">
<original>K</original>
<variation>R</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CDK2-induced activity in the absence, but not in the presence, of progestin. Delayed nuclear translocation in presence of progestin." evidence="16 24">
<original>S</original>
<variation>A</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some loss of sumoylation; when associated with R-7. Completely abolishes sumoylation; when associated with R-7 and R-388." evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="531"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA36018." ref="1" evidence="41">
<original>G</original>
<variation>S</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA36018." ref="1" evidence="41">
<original>V</original>
<variation>S</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="turn" evidence="46">
<location>
<begin position="568"/>
<end position="570"/>
</location>
</feature>
<feature type="strand" evidence="46">
<location>
<begin position="576"/>
<end position="578"/>
</location>
</feature>
<feature type="strand" evidence="46">
<location>
<begin position="581"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="46">
<location>
<begin position="585"/>
<end position="596"/>
</location>
</feature>
<feature type="strand" evidence="46">
<location>
<begin position="604"/>
<end position="607"/>
</location>
</feature>
<feature type="turn" evidence="46">
<location>
<begin position="613"/>
<end position="618"/>
</location>
</feature>
<feature type="helix" evidence="46">
<location>
<begin position="620"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="686"/>
<end position="694"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="711"/>
<end position="735"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="739"/>
<end position="741"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="744"/>
<end position="771"/>
</location>
</feature>
<feature type="strand" evidence="45">
<location>
<begin position="774"/>
<end position="779"/>
</location>
</feature>
<feature type="strand" evidence="45">
<location>
<begin position="782"/>
<end position="784"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="786"/>
<end position="788"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="792"/>
<end position="811"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="815"/>
<end position="826"/>
</location>
</feature>
<feature type="strand" evidence="45">
<location>
<begin position="828"/>
<end position="830"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="838"/>
<end position="857"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="863"/>
<end position="896"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="898"/>
<end position="901"/>
</location>
</feature>
<feature type="helix" evidence="45">
<location>
<begin position="907"/>
<end position="921"/>
</location>
</feature>
<feature type="strand" evidence="45">
<location>
<begin position="925"/>
<end position="927"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q00175"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000256">
<source>
<dbReference type="SAM" id="MobiDB-lite"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10628747"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10655479"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10757795"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11041221"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11110801"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11546784"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12039952"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12644308"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12917342"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1517211"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15572662"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15798179"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1587864"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16478993"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17020914"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17173941"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17347654"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17717077"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18202149"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22031296"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2328727"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23518922"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3551956"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7476977"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7969170"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8180103"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8264658"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8702648"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9171245"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9407067"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="37" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12644308"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="41" type="ECO:0000305"/>
<evidence key="42" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10757795"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11546784"/>
</source>
</evidence>
<evidence key="44" type="ECO:0007744">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="45" type="ECO:0007829">
<source>
<dbReference type="PDB" id="1SQN"/>
</source>
</evidence>
<evidence key="46" type="ECO:0007829">
<source>
<dbReference type="PDB" id="5CC0"/>
</source>
</evidence>
<sequence length="933" mass="98981" checksum="80452E54FF3A0454" modified="2006-03-21" version="4">MTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFPGSQTSDTLPEVSAIPISLDGLLFPRPCQGQDPSDEKTQDQQSLSDVEGAYSRAEATRGAGGSSSSPPEKDSGLLDSVLDTLLAPSGPGQSQPSPPACEVTSSWCLFGPELPEDPPAAPATQRVLSPLMSRSGCKVGDSSGTAAAHKVLPRGLSPARQLLLPASESPHWSGAPVKPSPQAAAVEVEEEDGSESEESAGPLLKGKPRALGGAAAGGGAAAVPPGAAAGGVALVPKEDSRFSAPRVALVEQDAPMAPGRSPLATTVMDFIHVPILPLNHALLAARTRQLLEDESYDGGAGAASAFAPPRSSPCASSTPVAVGDFPDCAYPPDAEPKDDAYPLYSDFQPPALKIKEEEEGAEASARSPRSYLVAGANPAAFPDFPLGPPPPLPPRATPSRPGEAAVTAAPASASVSSASSSGSTLECILYKAEGAPPQQGPFAPPPCKAPGASGCLLPRDGLPSTSASAAAAGAAPALYPALGLNGLPQLGYQAAVLKEGLPQVYPPYLNYLRPDSEASQSPQYSFESLPQKICLICGDEASGCHYGVLTCGSCKVFFKRAMEGQHNYLCAGRNDCIVDKIRRKNCPACRLRKCCQAGMVLGGRKFKKFNKVRVVRALDAVALPQPVGVPNESQALSQRFTFSPGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>